Skip to content
Search

Latest Stories

'Deprived areas of  England witnessed 41% pharmacy closure in last seven year'

The Company Chemists’ Association (CCA)’s research has found that between 2015 and 2022 more than 40 per cent of permanent community pharmacy closures took place in the 20 per cent most deprived parts of England.

The association has analyzed the NHS data and found that between 2015 and 2022, 808 pharmacies closed permanently in England. In that period, only 138 new pharmacies opened – a net loss of 670 community pharmacies.


It also examined where permanent closures had taken place. “41% of net permanent closures had taken place in the top 20% most deprived areas in England. Meanwhile, only 9% of net permanent closures took place in the top 20% least deprived areas.”

Although the latest figures for 2021/22 suggest that the overall rate of closures may be slowing down, the proportion of pharmacies permanently shutting in more deprived areas has only increased.

An even larger share of pharmacies that permanently shut in 2021/22 occurred in the most deprived areas compared with the previous fiscal year: 44% of net closures took place within the bottom two IMD deciles.

Although a national problem, the North and West Midlands were found to have shouldered a heavy burden of closures in most deprived areas. 63% of closures in the most deprived areas were concentrated in the Northwest, West Midlands, and Yorkshire and Humber.

Breakdown of permanent net closures by region in England

Total Net Closures per Region(2015/16 - 2021/22)aTotal Net Closures in

Most Deprived Areas per Region

(2015/16 - 2021/22)b
Proportion of Closures in Deprived Areas (% of Total Closures) per Region(2015/16 - 2021/22)c
North West-132-7859%
South East-101-1111%
West Midlands-91-5864%
London-76-1722%
Yorkshire and The Humber-76-3951%
South West-70-2333%
East of England-42-1536%
East Midlands-41-1332%
North East-39-2051%

The CCA is concerned that permanent closures will undermine healthcare accessibility in deprived areas, where access tends to be more limited despite greater need (the ‘inverse care law’). The reverse is true for community pharmacy – 89.2% of the population is estimated to have access to a community pharmacy within a 20-minute walk, and crucially in areas of highest deprivation access is significantly higher (99.8%) – otherwise known as the ‘positive pharmacy care law’. Moreover, ‘underserved’ communities may be more likely to visit their local pharmacy, according to NICE guidelines.

NHS England has devised ‘Core20PLUS5’, a national and Integrated Care System-level approach to reducing health inequalities in the top 20% most deprived populations by focusing on five areas of clinical focus such as chronic respiratory disease and hypertension case-finding.

Malcolm Harrison, Chief Executive of the CCA said: "Research shows that population health is greatly affected by standards of nutrition, housing, working environment and education.  Therefore, access to healthcare needs to be greater in areas of higher deprivation.  Unfortunately, the opposite is true, with access to general practice often better in more affluent areas. However, we know that there is greater access to community pharmacies in deprived areas.

Pharmacies continue to close disproportionately in areas of deprivation at a concerning rate. Closures will only worsen the health of deprived communities. The CCA is concerned that individuals may not be able to visit pharmacies at all to either get the medicines and advice they need or to be referred into other parts of the system.

The current funding model for community pharmacy is broken. The pharmacy network is no longer economically viable. The Government must face the facts and stop pharmacy closures by providing a sustainable level of funding. Without action, the country is sleepwalking towards an ever-worsening crisis in primary care – which threatens the entire ‘levelling up’ agenda for people in the most deprived communities.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less